中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

43 records (took 0.022 seconds)

    METHODS, COMPOSITIONS AND KITS FOR PERFORMING ANASTOMOSIS PROCEDURES IN CONJUNCTION WITH A RADICAL PROSTATECTOMY PROCEDURE
    11.
    发明申请
    METHODS, COMPOSITIONS AND KITS FOR PERFORMING ANASTOMOSIS PROCEDURES IN CONJUNCTION WITH A RADICAL PROSTATECTOMY PROCEDURE 有权
    方法，组合物和用于与RADICAL PROSTATECTOMY PROCEDURE一起执行分析程序的组合物

    公开(公告)号：US20150257761A1

    公开(公告)日：2015-09-17

    申请号：US14715107

    申请日：2015-05-18

    Applicant: Boston Scientific Scimed, Inc.

    Inventor： David E. Ahonen ,  Wendy Bosworth ,  Jianmin Li

    IPC: A61B17/11 ,  A61B17/12

    CPC classification number: A61B17/11 ,  A61B17/00 ,  A61B17/00491 ,  A61B17/12045 ,  A61B17/12159 ,  A61B17/12181 ,  A61B17/12195 ,  A61B2017/00274 ,  A61B2017/1132 ,  A61B2018/00505 ,  A61B2018/00517 ,  A61F2/04 ,  A61F2/86 ,  A61F2002/041 ,  A61F2210/0014

    Abstract: In some aspects, a surgical procedure for the removal of a prostate gland is provided. The procedure comprises: (a) positioning an implant material within the urethra, (b) removing the prostate, thereby cresting a urethral stump and a bladder neck, wherein the implant material occupies the urethral stump, the bladder neck, or both, and (c) securing the bladder neck to the urethral stump in an anastomosis procedure to establish a path of urine flow from the bladder to an external urethral opening (e.g., the meatus). Subsequently, the implant material is removed from the urethra, for example, by natural urine voiding or by flowing a removal fluid through and/or around the implant material in the urethra. In other aspects, a medical kit is provided.

    Abstract translation: 在一些方面，提供了用于去除前列腺的外科手术。 该方法包括：（a）将植入材料定位在尿道内，（b）去除前列腺，从而起伏尿道残端和膀胱颈部，其中植入材料占据尿道残端，膀胱颈或两者，和（ c）在吻合过程中将膀胱颈部固定到尿道残端，以建立尿液从膀胱流向外部尿道开口（例如，口）的路径。 随后，例如通过天然尿液排泄或通过使去除液体流过尿道中的植入材料和/或周围的植入材料从尿道中移除植入材料。 在其他方面，提供医疗工具包。

    URETERAL STENT
    12.
    发明申请
    URETERAL STENT 有权
    不稳定的

    公开(公告)号：US20150250581A1

    公开(公告)日：2015-09-10

    申请号：US14722844

    申请日：2015-05-27

    Applicant: Boston Scientific Scimed, Inc.

    Inventor： Isaac Ostrovsky ,  Jozef Slanda ,  Jianmin Li ,  Hamid Davoudi ,  Robert T. Miragliuolo

    IPC: A61F2/04

    CPC classification number: A61F2/042 ,  A61F2/82 ,  A61L31/128 ,  A61M25/00 ,  A61M27/008 ,  C08L23/12

    Abstract: In some embodiments, a ureteral stent includes an elongate member having a first portion and a second portion, which is coupled to the first portion. The first portion of the elongate member is configured to be disposed within a kidney of a patient. The second portion of the elongate member, which has a sidewall that defines a lumen, is configured to deliver fluid from a first location of the sidewall of the second portion to a second location of the sidewall of the second portion via capillary action. The second portion of the elongate member is configured to be disposed within at least one of a bladder and a ureter of the patient.

    Abstract translation: 在一些实施例中，输尿管支架包括具有第一部分和第二部分的细长构件，其连接到第一部分。 细长构件的第一部分被配置为设置在患者的肾脏内。 具有限定内腔的侧壁的细长构件的第二部分构造成通过毛细作用将流体从第二部分的侧壁的第一位置输送到第二部分的侧壁的第二位置。 细长构件的第二部分构造成设置在患者的膀胱和输尿管中的至少一个中。

    CONTROLLING RESORPTION OF BIORESORBABLE MEDICAL IMPLANT MATERIAL
    15.
    发明申请
    CONTROLLING RESORPTION OF BIORESORBABLE MEDICAL IMPLANT MATERIAL 失效
    控制生物体医用植物材料的再生

    公开(公告)号：US20130084315A1

    公开(公告)日：2013-04-04

    申请号：US13685295

    申请日：2012-11-26

    Applicant: Boston Scientific Scimed, Inc.

    Inventor： Jianmin Li ,  Samuel Baldwin ,  Timothy P. Harrah

    IPC: A61L31/14 ,  A61F2/00 ,  A61B17/12 ,  A61F2/04 ,  A61L31/10 ,  A61F2/02

    CPC classification number: A61L31/148 ,  A61B17/12113 ,  A61F2/0004 ,  A61F2/02 ,  A61F2/04 ,  A61F2210/0004 ,  A61F2210/009 ,  A61L27/40 ,  A61L27/58 ,  A61L29/085 ,  A61L29/148 ,  A61L29/16 ,  A61L31/10 ,  A61L31/12 ,  A61L31/16 ,  A61L2300/00

    Abstract: The resorption of a medical implant can be controlled with the use of particles embedded in a resorbable bulk material forming the implant or portion thereof. The implant can be removed from a body of a mammal by natural biological mechanisms after use. The resorption of the implant can involve swelling and/or hydrolyzing of the particles within the implant upon contact with a body fluid such that porosity and flow of fluid within the bulk material of the implant is increased. Resorption of the implant may also involve the use of particles with magnetic properties embedded within the implant such that an applied magnetic field causes the particles to vibrate within the bulk material thereby increasing the porosity and thus the flow of fluid, hence facilitating resorption of the implant. The resorption rate of the implant can be controlled by modulating swelling, hydrolysis, or movement of the embedded particles.

    Abstract translation: 可以通过使用嵌入到形成植入物或其部分的可再吸收散装材料中的颗粒来控制医用植入物的吸收。 植入物可以在使用后通过天然生物学机制从哺乳动物的身体中去除。 植入物的吸收可以包括在与体液接触时使植入物内的颗粒溶胀和/或水解，使得植入物的体积材料内的流体的孔隙率和流量增加。 植入物的再吸收还可以涉及使用具有嵌入在植入物内的磁特性的颗粒，使得所施加的磁场使得颗粒在体材料内振动，从而增加孔隙率，从而增加流体的流动，从而促进植入物的再吸收 。 植入物的吸收速率可通过调节嵌入颗粒的溶胀，水解或运动来控制。

    Porous ureteral stent
    17.
    发明授权
    Porous ureteral stent 有权

    公开(公告)号：US10258485B2

    公开(公告)日：2019-04-16

    申请号：US14931434

    申请日：2015-11-03

    Applicant: Boston Scientific Scimed, Inc.

    Inventor： Hamid Davoudi ,  Alfred P. Intoccia, Jr. ,  Jianmin Li

    IPC: A61F2/82 ,  A61F2/04 ,  A61M25/00 ,  A61M27/00

    Abstract: In some embodiments, a stent includes an elongate member and a distal retention member. The elongate member is configured to be disposed within a ureter of a patient and has a first portion, a second portion and a plurality of beads bonded together. The plurality of beads define a plurality of spaces between the plurality of beads. The plurality of spaces are configured to allow fluid to flow from the first portion of the elongate member to the second portion of the elongate member. The distal retention member is configured to help maintain a portion of the stent within a kidney of the patient.

    Method and device for tissue removal and for delivery of a therapeutic agent or bulking agent
    18.
    发明授权
    Method and device for tissue removal and for delivery of a therapeutic agent or bulking agent 有权

    公开(公告)号：US09808610B2

    公开(公告)日：2017-11-07

    申请号：US13970675

    申请日：2013-08-20

    Applicant: Boston Scientific Scimed Inc.

    Inventor： Jianmin Li ,  Weenna Bucay-Couto

    IPC: A61M37/00 ,  A61B17/22 ,  A61B17/32 ,  A61B10/02 ,  A61B17/00 ,  A61B17/3207 ,  A61B18/00

    CPC classification number: A61M37/00 ,  A61B10/0241 ,  A61B17/22 ,  A61B17/32002 ,  A61B2017/00274 ,  A61B2017/00685 ,  A61B2017/320775 ,  A61B2018/00547

    Abstract: According to an aspect of the present invention, a medical device is provided, which comprises the following: (a) a hollow elongate body (e.g., a elongate cylinder, such as a needle) having distal and proximal ends; and (b) a rotatable member comprising a tissue morselizer and an elongate shaft (e.g., an auger-like tissue-drilling bit). In the devices of the present invention, the elongate shaft is disposed within the hollow elongate body and cooperates with the hollow elongate body to (i) advance material (e.g., morselated tissue) toward the proximal end of the hollow elongate body when the shaft is rotated in a first direction, and (ii) advance material (e.g., a therapeutic agent and/or a bulking agent) toward the distal end of the hollow elongate body when the shaft is rotated in a second direction that is opposite the first direction. According to another aspect of the invention a method of treatment is provided that comprises: (a) inserting the a medical device like that above into the tissue of a patient; (b) morselizing and removing tissue from within the patient while rotating the shaft in a first direction, thereby creating a void within the patient; and (c) introducing a therapeutic agent and/or a bulking agent into the void.

    Tissue extraction devices and related methods
    19.
    发明授权
    Tissue extraction devices and related methods 有权

    公开(公告)号：US09801651B2

    公开(公告)日：2017-10-31

    申请号：US14692926

    申请日：2015-04-22

    Applicant: Boston Scientific Scimed, Inc.

    Inventor： Timothy Harrah ,  Jozef Slanda ,  Jianmin Li ,  Prateet Verma

    IPC: A61B17/3205 ,  A61B17/221 ,  A61B17/00

    CPC classification number: A61B17/32056 ,  A61B17/221 ,  A61B2017/00353

    Abstract: According to one aspect, a medical device may include a luminal element configured for insertion into a natural body lumen. The medical device may further include a tool configured to be received within the luminal element. The tool may include a plurality of operating members. Each of the operating members may include an elongate member and a cutting member. The cutting member may be located at a distal end of the elongate member. Further, the cutting member of a first operating member of the plurality of operating members may be rotatable with respect to the cutting member of a second operating member of the plurality of operating members.

    Ureteral stent with drug-releasing structure
    20.
    发明授权
    Ureteral stent with drug-releasing structure 有权
    具有药物释放结构的输尿管支架

    公开(公告)号：US09445884B2

    公开(公告)日：2016-09-20

    申请号：US14164316

    申请日：2014-01-27

    Applicant: Boston Scientific Scimed Inc.

    Inventor： Heidi J. Barron ,  Jianmin Li

    IPC: A61F2/04 ,  A61M27/00 ,  A61K31/00 ,  A61L31/14 ,  A61L31/16 ,  A61K9/00

    CPC classification number: A61F2/04 ,  A61F2002/048 ,  A61F2210/0004 ,  A61F2220/0008 ,  A61F2250/0067 ,  A61K9/0036 ,  A61K31/00 ,  A61L31/148 ,  A61L31/16 ,  A61M27/008

    Abstract: According to one aspect of the present disclosure, ureteral stents are provided that comprise an elongated stent body, at least one deployable retention structure, and at least one sleeve and/or sheet of drug-releasing material. In various embodiments, at least one sleeve and/or sheet of drug-releasing material is deployed concurrently with the deployment of at least one deployable retention structure. The ureteral stents of the present disclosure are adapted to release the urologically beneficial drug into a subject.

    Abstract translation: 根据本公开的一个方面，提供输尿管支架，其包括细长的支架主体，至少一个可展开的保持结构以及至少一个药物释放材料的套管和/或片。 在各种实施方案中，药物释放材料的至少一个套筒和/或片材与至少一个可部署的保留结构的展开同时部署。 本公开的输尿管支架适于将泌尿学有益的药物释放到受试者中。

Patent Agency Ranking